Rat Model Market – Industry Growth, Dynamics, Segmentation and Forecast

marketsandmarkets

Pune, India, 2020-Jan-27 — /EPR Network/ —

According to the new market research report “Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

The Global Rat ModelMarket is expected to reach $588.9 Million, growing at a CAGR of 8.7%

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76036494

The market is segmented on the basis of model type, service, therapeutic area, technology, end-user, care product, and region.

On the basis of model type, the market is categorized into the outbred rats, inbred rats, knockout/genetically modified rats, conditioned/surgically modified rats, hybrid/congenic rats, and immunodeficient rats. In 2016, the outbred rats segment is estimated to account for the largest share of the global market. However, the knockout/genetically modified rats segment is expected to be the fastest-growing segment owing to the use of this type of rat models to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, aging, and Parkinson’s disease.

Browse and in-depth TOC on “Rat Model Market

132 – Tables

47 – Figures

253 – Pages

On the basis of service, the market is segmented into breeding, quarantine, rederivation, cryopreservation, genetic testing, model-in-licensing, and other services (surgical services, line rescue services, and in vivo pharmacology services). In 2016, the breeding services segment is expected to command the largest share of the global market.

On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutions, and contract research organizations (CROs). In 2016, the pharmaceutical & biotechnology companies segment is expected to command the largest share of the global market.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76036494

Charles River Laboratories International, Inc. (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), Biomere (U.S.), Janvier Labs (France), genOway SA (France), and Horizon Discovery Group plc (U.K.) are some of the key players in the rat model market worldwide.

Matched content

Editor’s pick